FDA Drug recall D-0583-2024
Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA…
- FDA Drug
- Class II
- terminated
- Published 2024-07-10
On 2024-07-10 the FDA classified a Class II recall of Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA… by Dr Reddy S Laboratories, citing presence of foreign substance.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0583-2024 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-06-07 |
| Published | 2024-07-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | IL, MS, OH |
Product
Allopurinol Tablets, USP 300mg, 100 Tablets per bottle, Rx only, Manufactured By: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106 USA, NDC 55111-730-01.
Reason
Presence of foreign substance.
Identifiers
| ndc | 55111-729-01 |
|---|---|
| ndc | 55111-729-10 |
| ndc | 55111-730-01 |
| ndc | 55111-730-05 |
| code_info | L2300594 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0583-2024%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.